tetano
Editor, Senior Moderator
Clin Infect Dis. 2015 Mar 31. pii: civ261. [Epub ahead of print]
[h=1]Comparative Effectiveness of High-Dose versus Standard-Dose Influenza Vaccination in Community-Dwelling Veterans.[/h] Richardson DM[SUP]1[/SUP], Medvedeva EL[SUP]1[/SUP], Roberts CB[SUP]1[/SUP], Linkin DR[SUP]2[/SUP]; CDC Prevention Epicenter Program.
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza is a significant cause of morbidity and mortality in older adults. High-dose (HD) trivalent inactivated vaccine has increased immunogenicity in older adults compared with standard-dose (SD) vaccine. We assessed the relative effectiveness of HD influenza vaccination (versus SD influenza vaccination).
[h=4]METHODS:[/h] We conducted a retrospective cohort study among patients who receive primary care at Veteran Health Administration (VHA) Medical Centers, and who received influenza vaccine in the 2010-2011 influenza season. The primary outcome was hospitalization for influenza or pneumonia. We also conducted an analysis in subgroups defined by age.
[h=4]RESULTS:[/h] We evaluated 25,714 patients who received HD vaccine and 139,511 who received SD vaccine in 23 VHA Medical Centers. The rate of hospitalization for influenza or pneumonia was 0.3% in both groups in the influenza season. After accounting for patient characteristics in propensity-adjusted analyses, the risk of hospitalization for influenza or pneumonia was not significantly lower among patients receiving HD vaccine, compared to SD vaccine (risk ratio, 0.98; 95% confidence interval, 0.68-1.40). In the subgroup of patients ≥85 years of age, receiving HD (compared with SD) vaccine was associated with lower rates of hospitalization for influenza or pneumonia.
[h=4]CONCLUSION:[/h] HD vaccine was not found to be more effective than SD vaccine in protecting against hospitalization for influenza or pneumonia, however, we found a protective effect in the oldest subgroup of patients. Additional studies are needed to evaluate the effectiveness of HD vaccine.
Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
PMID: 25829001 [PubMed - as supplied by publisher]
[h=1]Comparative Effectiveness of High-Dose versus Standard-Dose Influenza Vaccination in Community-Dwelling Veterans.[/h] Richardson DM[SUP]1[/SUP], Medvedeva EL[SUP]1[/SUP], Roberts CB[SUP]1[/SUP], Linkin DR[SUP]2[/SUP]; CDC Prevention Epicenter Program.
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza is a significant cause of morbidity and mortality in older adults. High-dose (HD) trivalent inactivated vaccine has increased immunogenicity in older adults compared with standard-dose (SD) vaccine. We assessed the relative effectiveness of HD influenza vaccination (versus SD influenza vaccination).
[h=4]METHODS:[/h] We conducted a retrospective cohort study among patients who receive primary care at Veteran Health Administration (VHA) Medical Centers, and who received influenza vaccine in the 2010-2011 influenza season. The primary outcome was hospitalization for influenza or pneumonia. We also conducted an analysis in subgroups defined by age.
[h=4]RESULTS:[/h] We evaluated 25,714 patients who received HD vaccine and 139,511 who received SD vaccine in 23 VHA Medical Centers. The rate of hospitalization for influenza or pneumonia was 0.3% in both groups in the influenza season. After accounting for patient characteristics in propensity-adjusted analyses, the risk of hospitalization for influenza or pneumonia was not significantly lower among patients receiving HD vaccine, compared to SD vaccine (risk ratio, 0.98; 95% confidence interval, 0.68-1.40). In the subgroup of patients ≥85 years of age, receiving HD (compared with SD) vaccine was associated with lower rates of hospitalization for influenza or pneumonia.
[h=4]CONCLUSION:[/h] HD vaccine was not found to be more effective than SD vaccine in protecting against hospitalization for influenza or pneumonia, however, we found a protective effect in the oldest subgroup of patients. Additional studies are needed to evaluate the effectiveness of HD vaccine.
Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
PMID: 25829001 [PubMed - as supplied by publisher]